Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Steroidogenesis Inhibitors (STGI)

No earlier versions found for this Subject.

Return to Steroidogenesis Inhibitors (STGI)

STGI has just recently begun trading. The company is run by Dr. Alfred Sapse, a world renown researcher. The company has developed a drug called ANTI-CORT which is a drug used in the AIDS drug "cocktail." Anti-Cort is currently going through the double blind study for FDA approval here, but already is available in international markets. Has anyone heard anything else on this company? I think they might be bought out by a larger pharmaceutical company down the road.

Bert